Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $142.0100 (1.18%) ($140.0000 - $144.9500) on Wed. Jan. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.43% (three month average) | RSI | 60 | Latest Price | $142.0100(1.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.7% a day on average for past five trading days. | Weekly Trend | LGND advances 2.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(55%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.715% in a week (0% probabilities). VXX(-15%) TLT(-15%) VIXM(-10%) UUP(-10%) DIA(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.715% (StdDev 3.43%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $139.04(2.14%) | 10 Day Moving Average | $137.96(2.94%) | 20 Day Moving Average | $137.33(3.41%) | To recent high | -39.6% | To recent low | 10.6% | Market Cap | $2.282b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |